首页|双层含骨基质骨器官芯片的构建

双层含骨基质骨器官芯片的构建

扫码查看
目的 构建双层含骨基质骨器官芯片并用于体外模拟成骨细胞和破骨细胞分化,为抗骨质疏松药物开发提供新平台.方法 使用WorkSoild软件制作双层双通道骨器官芯片设计图,利用光刻技术制备浇注母版.以聚二甲基硅氧烷(PDMS)为原料,通过模具浇注制备芯片主体.以牛皮质骨片为间隔,分隔培养室4个通道进出口采用储液柱封闭.芯片验证实验分为成骨、破骨诱导组和成骨、破骨对照组,成骨、破骨诱导组将小鼠胚胎成骨细胞前体细胞MC3T3-E1和小鼠巨噬细胞RAW264.7分别接种于芯片上,成骨诱导14 d,破骨诱导7 d.成骨、破骨对照组为不进行诱导的MC3T3-E1细胞和RAW264.7细胞.观察指标包括:(1)芯片外观及密封性:芯片制备完成后拍照观察外观并通过密封实验观察密封性能.(2)生物相容性:MC3T3-E1细胞和RAW264.7细胞接种于芯片培养3d及培养1、3、5d后,分别采用钙黄绿素乙酰氧基甲酯/碘化丙啶(AM/PI)染色和细胞增殖及毒性检测试剂盒(CCK-8)实验观察细胞存活情况.(3)成骨分化情况:对成骨诱导组细胞进行碱性磷酸酶(ALP)染色、茜素红染色观察成骨细胞诱导情况.收集成骨诱导组和成骨对照组细胞RNA,qPCR检测成骨细胞标志基因Runt相关转录因子2(RUNX2)、骨钙素(OCN)、Ⅰ型胶原(COL1A1)表达情况,观察成骨细胞分化程度和成骨能力.(4)破骨分化情况:对破骨诱导组细胞进行抗酒石酸酸性磷酸酶(TRAP)染色观察破骨细胞分化情况.提取破骨诱导组和破骨对照组细胞RNA进行破骨分化基因qPCR,检测破骨细胞标志基因TRAP、组织蛋白酶K(CTSK)和树突状细胞特异性跨膜蛋白(DC-STAMP)表达水平.结果 双层含骨基质骨器官芯片大小为3cm×3 cm,整体透光,芯片系统结构对接紧凑,无渗液.钙黄绿素AM/PI染色结果显示,MC3T3-E1细胞和RAW264.7细胞培养3 d后,呈红色荧光死细胞极少.CCK-8实验结果显示,MC3T3-E1细胞和RAW264.7细胞培养5 d内,细胞活力均在90%以上,表明芯片生物相容性好,细胞可以正常存活并增殖.ALP染色和茜素红染色结果显示,成骨诱导14 d,成骨诱导组MC3T3-E1细胞成功分化为成骨细胞并产生钙化结节.qPCR结果显示,成骨诱导组MC3T3-E1细胞的RUNX2相对表达量为4.98±0.74,显著高于对照组的0.99± 0.03(P<0.01);MC3T3-E1细胞的OCN相对表达量为7.98±0.76,显著高于对照组的1.00±0.06(P<0.01);MC3T3-E 1细胞的COL1A1相对表达量为7.07±0.56,显著高于对照组的0.97±0.03(P<0.01).TRAP染色结果显示,破骨诱导7 d,破骨诱导组RAW264.7细胞形成巨大的多核破骨细胞,破骨细胞表达大量TRAP蛋白.qPCR检测结果显示,破骨诱导组RAW264.7细胞的TRAP相对表达量为3.35± 0.37,显著高于对照组的1.01±0.06(P<0.01);RAW264.7细胞的CTSK相对表达量为3.46±0.79,显著高于对照组的1.01±0.05(P<0.01);RAW264.7细胞的DC-STAMP相对表达量为1.92±0.12,显著高于对照组的0.98±0.08(P<0.01).结论 双层含骨基质骨器官芯片结构紧凑,可长期体外培养,生物相容性好,可进行成骨和破骨细胞分化诱导,有望为骨质疏松机制探究和药物筛选提供新的研究平台.
Construction of double-layer bone-on-a-chip containing bone matrix
Objective To construct a double-layer bone-on-a-chip containing bone matrix,with which the process of osteoblast and osteoclast differentiation in vitro is stimulated,aiming to provide a new platform for the development of osteoporosis medications.Methods Software WorkSoild was used to design the double-layer and double-channel bone-on-a-chip and the template was fabricated by photolithography.With polydimethylsiloxane(PDMS)as the raw material,the main body of the chip was prepared by mold fabrication.The inlets and outlets of the four channels of the culture room were separated with bovine cortex bones and sealed with liquid storage columns.In the chip verification experiment,chips were divided into osteogenic and osteoclastic induction groups and osteogenic and osteoclastic control groups.In the osteogenic and osteoclastic induction groups,precursor cells of mouse embryonic osteoblast,MC3T3-E1 and mouse macrophage RAW264.7 were inoculated on the chip separately.Osteogenic induction lasted 14 days and osteoclastic induction 7 days.MC3T3-E1 cells and RAW264.7 cells were not induced in the osteogenic and osteoclastic control groups.The following indicators were observed:(1)Appearance and sealing performance of the chip:After the chip was prepared,photos were taken to observe its appearance and sealing tests were conducted to observe its sealing performance.(2)Biocompatibility:At 3 days after MC3T3-E1 cells were inoculated onto the chip and cultured and at 1,3 and 5 days after RAW264.7 cells were inoculated onto the chip and cultured,the cell survival was observed with calcein acetoxymethyl ester/propidium iodide(AM/PI)staining and Cell Counting Kit 8(CCK-8).(3)Osteogenic differentiation:Alkaline phosphatase(ALP)staining and alizarin red staining were performed on the cells in the osteogenic induction group to observe the osteogenic induction.RNA was collected from the osteogenic induction group and the osteogenic control group,the expression of osteoblast marker Runt-related transcription factor 2(RUNX2),osteocalcin(OCN)and type Ⅰ collagen(COL1A1)was detected by real-time florescent quantitative PCR(qPCR),and the differentiation degree and osteogenic ability of osteoblasts were observed.(4)Osteoclast differentiation:tartrate-resistant acid phosphatase(TRAP)staining was performed on cells in the osteoclastic induction group to observe osteoclast differentiation.RNA was extracted from the osteoclastic induction group and the osteoclastic control group for qPCR of osteoclast differentiation-related genes,and the expression levels of the osteoclast marker gene TRAP,cathepsin K(CTSK)and dendritic cell specific transmembrane protein(DC-STAMP)were detected.Results The double-layer bone-on-a-chip containing bone matrix was 3 cm×3 cm in size and transparent as a whole.The structure of the system on the chip system was compact and had no seepage.It was shown by calcein AM/PI staining that at 3 days after MC3T3-E1 cells and RAW264.7 cells were cultured,very few red fluorescent dead cells were found.CCK-8 test showed that within 5 days after being cultured,the cell viability was all above 90%,indicating that the biocompatibility of the chip was good and the cells could survive and proliferate normally.The results of ALP and alizarin red staining showed that MC3T3-E1 cells successfully differentiated into osteoblasts and produced calcified nodules in the osteogenic induction group at 14 days after the induction.The qPCR results showed that the relative expression level of RUNX2 in MC3T3-E1 cells in the osteogenic induction group was 4.98±0.74,which was significantly higher than that of the control group(0.99±0.03)(P<0.01).The relative expression level of OCN in MC3T3-E1 cells was 7.98±0.76,which was significantly higher than that of the control group(1.00±0.06)(P<0.01).The relative expression level of COL1A1 in MC3T3-E1 cells was 7.07±0.56,which was significantly higher than that of the control group(0.97±0.03)(P<0.01).The TRAP staining results showed that the RAW264.7 cells in the osteoclastic induction group differentiated to giant multinucleated osteoclasts,and TRAP protein was expressed in large quantity in the osteoclasts.The results of qPCR showed that the relative expression level of TRAP in RAW264.7 cells in the osteoclastic induction group was 3.35±0.37,which was significantly higher than that of the control group(1.01±0.06)(P<0.01).The relative expression level of CTSK in RAW264.7 cells was 3.46±0.79,which was significantly higher than that of the control group(1.01±0.05)(P<0.01).The relative expression level of DC-STAMP in RAW264.7 cells was 1.92±0.12,which was significantly higher than that of the control group(0.98±0.08)(P<0.01).Conclusions The double-layer bone-on-a-chip containing bone matrix is compact in structure,can be cultured in vitro for a long time,has good biocompatibility and can be used for inducing osteogenic and osteoclast differentiation.Therefore,it is expected to provide a new research platform for exploring the mechanism of osteoporosis and medication screening.

OsteoporosisOrganoidsBone remodelingOsteoblastsOsteoclastsOrgan-on-a-chip

张浩、周晨阳、胡衍、陈晓、王晓林、苏佳灿

展开 >

上海交通大学医学院附属新华医院骨科,上海 200092

上海大学转化医学研究院,上海 200444

上海交通大学电子信息与电气工程学院,上海 200240

骨质疏松 类器官 骨重建 成骨细胞 破骨细胞 器官芯片

国家自然科学基金重点项目国家自然科学基金重大集成项目上海科学技术委员会实验动物专项中国博士后科学基金国家资助博士后研究人员计划

8223007192249303231419006002023M732179GZB20230397

2024

中华创伤杂志
中华医学会

中华创伤杂志

CSTPCD北大核心
影响因子:1.425
ISSN:1001-8050
年,卷(期):2024.40(1)
  • 1
  • 8